Jana Medical Company (TADAWUL:9616)

Jana Medical Company Balance Sheet

Financials in millions SAR. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022
Cash & Equivalents	18.44	1.71	1.43
Cash & Short-Term Investments	18.44	1.71	1.43
Cash Growth	977.37%	20.03%	-
Accounts Receivable	45.26	68.17	40.47
Other Receivables	10.99	-	4.94
Receivables	56.25	68.17	45.41
Inventory	2.73	1.6	10.34
Prepaid Expenses	0.74	1.08	0.3
Other Current Assets	5.53	3.89	3.98
Total Current Assets	83.69	76.45	61.46
Property, Plant & Equipment	0.85	1.35	1.72
Other Intangible Assets	0.11	0.08	0
Total Assets	84.66	77.88	63.18
Accounts Payable	2.71	3.36	3.29
Accrued Expenses	3.84	2.54	2.12
Short-Term Debt	-	4.88	-
Current Portion of Long-Term Debt	22.77	22.47	22.03
Current Portion of Leases	0.18	0.24	0.35
Current Income Taxes Payable	1.89	1.13	0.34
Other Current Liabilities	7.09	0.24	0.31
Total Current Liabilities	38.47	34.86	28.45
Long-Term Debt	5.69	4.98	2.02
Long-Term Leases	0.44	0.74	1.01
Total Liabilities	45.34	41.62	32.57
Common Stock	32.13	25.7	25.7
Additional Paid-In Capital	19.62	-	-
Retained Earnings	-12.43	10.56	4.91
Shareholders' Equity	39.32	36.26	30.61
Total Liabilities & Equity	84.66	77.88	63.18
Total Debt	29.08	33.31	25.41
Net Cash (Debt)	-10.64	-31.6	-23.98
Net Cash Per Share	-4.01	-12.29	-11.93
Filing Date Shares Outstanding	3.21	3.21	2.01
Total Common Shares Outstanding	3.21	3.21	2.01
Working Capital	45.22	41.58	33.01
Book Value Per Share	12.24	11.29	15.23
Tangible Book Value	39.21	36.18	30.61
Tangible Book Value Per Share	12.20	11.26	15.22
Machinery	0.63	0.63	0.48
Leasehold Improvements	0.1	0.1	0.1

Source: S&P Global Market Intelligence. Standard template. Financial Sources.